Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 4/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | PDE6D | O43924 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | TGM2 | P21980 | 2/20 | 0.41 |
| ▸ | THRA | P10827 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14173219 | 0.93 | THRB (0.58) | THRBRAB9APDE6DLMNATGM2 | |
| SCHEMBL15695636 | 0.93 | THRB (0.58) | THRBRAB9APDE6DLMNATGM2 | |
| SCHEMBL802752 | 0.93 | THRB (0.58) | THRBRAB9APDE6DLMNATGM2 | |
| SCHEMBL2583822 | 0.93 | THRB (0.58) | THRBRAB9APDE6DLMNATGM2 | |
| SCHEMBL31379798 | 0.93 | THRB (0.58) | THRBRAB9APDE6DLMNATGM2 | |
| SCHEMBL10694888 | 0.91 | THRB (0.56) | THRBRAB9APDE6DLMNATGM2 | |
| SCHEMBL140760 | 0.91 | THRB (0.56) | THRBKMT2AMEN1MAPTTDP1 | |
| SCHEMBL11772755 | 0.91 | THRB (0.56) | THRBRAB9APDE6DLMNATGM2 | |
| SCHEMBL25041907 | 0.89 | THRB (0.55) | THRBKMT2AHSD17B10MEN1ALDH1A1 | |
| SCHEMBL2585540 | 0.89 | THRB (0.55) | THRBLMNAKMT2AMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 391 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3699353-B1 | COATINGS | P2I LTD (GB) | 2026-04-01 | — | — | EP | claimed |
| EP-4658402-A1 | METAL ORGANIC FRAMEWORKS POLYMORPHISM FOR ADSORPTION PROFILE TUNING | Centre National de la Recherche Scientifique (FR) | 2025-12-10 | — | — | EP | claimed |
| CN-119920969-A | Solid electrolyte film, method for producing same, separator-free solid-state battery, and mechanical device | 重庆太蓝新能源有限公司 | 2025-05-02 | — | — | CN | claimed |
| WO-2024160984-A1 | METAL ORGANIC FRAMEWORKS POLYMORPHISM FOR ADSORPTION PROFILE TUNING | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-08-08 | — | — | WO | claimed |
| EP-3798243-B1 | MODIFIED CONJUGATED DIENE-BASED POLYMER AND METHOD FOR PREPARING SAME | LG CHEMICAL LTD (KR) | 2023-11-01 | — | — | EP | claimed |
| EP-3850018-B1 | ANTIMICROBIAL CONTACT LENSES | KERAMED INC (US) | 2023-08-23 | — | — | EP | claimed |
| US-11702497-B2 | Modified conjugated diene-based polymer and method for preparing same | LG CHEM, LTD. | 2023-07-18 | — | — | US | claimed |
| WO-2023078367-A1 | SECONDARY BATTERY | 珠海冠宇电池股份有限公司 | 2023-05-11 | — | — | WO | claimed |
| CN-115260418-A | Drag reducer for fracturing fluid and preparation method thereof | 山东诺尔生物科技有限公司 | 2022-11-01 | — | — | CN | claimed |
| US-20220259392-A1 | HOMOGENEOUS ANION EXCHANGE MEMBRANE AND BIOSENSING MEMBRANE PREPARED FROM THE SAME | YUAN ZE UNIVERSITY (TW) | 2022-08-18 | — | — | US | claimed |
| US-20220154032-A1 | COATINGS | P2I LTD (GB) | 2022-05-19 | — | — | US | claimed |
| CN-114087203-A | Integrated slurry pump and mold for manufacturing same | 汉江弘源襄阳碳化硅特种陶瓷有限责任公司 | 2022-02-25 | — | — | CN | claimed |
| US-5807497-A | CROSSLINKED LIQUID CRYSTALLINE POLYMERS | DAIMLER-BENZ AG (DE) | 1998-09-15 | — | — | US | claimed |
| EP-0760836-B1 | EFFECT LACQUER AND LACQUERING, IN PARTICULAR FOR CAR BODIES, BY MEANS OF LIQUID CRYSTAL INTERFERENCE PIGMENTS | DAIMLER BENZ AG (DE) | 1998-07-29 | — | — | EP | claimed |
| EP-0760836-A1 | EFFECT LACQUER AND LACQUERING, IN PARTICULAR FOR CAR BODIES, BY MEANS OF LIQUID CRYSTAL INTERFERENCE PIGMENTS | DAIMLER-BENZ AKTIENGESELLSCHAFT (DE) | 1997-03-12 | — | — | EP | claimed |
| WO-1995032247-A1 | EFFECT LACQUER AND LACQUERING, IN PARTICULAR FOR CAR BODIES, BY MEANS OF LIQUID CRYSTAL INTERFERENCE PIGMENTS | DAIMLER-BENZ AKTIENGESELLSCHAFT (DE) | 1995-11-30 | — | — | WO | claimed |
| JP-2020382-A | — | — | None | — | — | JP | disclosed |
| US-12635688-B2 | Process and solution for preparing a surface with bacteriostatic and bactericidal activity, surface thus prepared and uses thereof | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2026-05-26 | — | — | US | disclosed |
| US-4292389-A | Process for preparing photosensitive plates for printing | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1981-09-29 | — | — | US | disclosed |
| US-4288521-A | Process for the production of photosensitive plates for printing | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1981-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12635688-B2 | Process and solution for preparing a surface with bacteriostatic and bactericidal activity, surface thus prepared and uses thereof | LPO, C9, MSR1 | THRB 1319/4885RAB9A 3665/4885PDE6D 2504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.